Oxidation reactions in Parkinson's disease
- PMID: 2215972
Oxidation reactions in Parkinson's disease
Abstract
Free radicals generated from oxidation reactions may contribute to the pathogenesis of Parkinson's disease (PD). Free radicals are capable of reacting almost instantaneously with membrane lipids and causing lipid peroxidation, membrane injury, and cell death. Dopamine is metabolized by oxidation reactions capable of generating free radicals. Recent evidence indicates that the substantia nigra of patients with PD contains increased iron, which enhances oxidation, and decreased glutathione, which protects against the formation of free radicals. Further, the end products of lipid peroxidation are increased in the substantia nigra of patients with PD, supporting the notions that free radicals are being generated and may contribute to dopamine neuronal death. This hypothesis suggests that antioxidant therapies may slow the rate of progression of PD and raises concern that metabolites of levodopa therapy may accelerate the rate of neuronal degeneration.
Similar articles
-
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.Ann Neurol. 1992 Dec;32(6):804-12. doi: 10.1002/ana.410320616. Ann Neurol. 1992. PMID: 1471873 Review.
-
Oxidative mechanisms in nigral cell death in Parkinson's disease.Mov Disord. 1998;13 Suppl 1:24-34. Mov Disord. 1998. PMID: 9613715 Review.
-
A rationale for dopamine agonists as primary therapy for Parkinson's disease.Can J Neurol Sci. 1992 Feb;19(1 Suppl):108-12. Can J Neurol Sci. 1992. PMID: 1349262 Review.
-
Iron metabolism and Parkinson's disease.Mov Disord. 1998;13 Suppl 1:39-45. Mov Disord. 1998. PMID: 9613717 Review.
-
Neurotoxicity and neuroprotection in Parkinson's disease.J Neural Transm Suppl. 1992;38:27-44. J Neural Transm Suppl. 1992. PMID: 1491247 Review.
Cited by
-
Exercise protects against MPTP-induced neurotoxicity in mice.Brain Res. 2010 Jun 23;1341:72-83. doi: 10.1016/j.brainres.2010.01.053. Epub 2010 Jan 29. Brain Res. 2010. PMID: 20116369 Free PMC article.
-
Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Neurotox Res. 2013 Apr;23(3):267-300. doi: 10.1007/s12640-012-9337-4. Epub 2012 Jun 28. Neurotox Res. 2013. PMID: 22739839 Review.
-
Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists.Curr Treat Options Neurol. 2001 Nov;3(6):479-493. doi: 10.1007/s11940-001-0011-z. Curr Treat Options Neurol. 2001. PMID: 11581525
-
Initial treatment of Parkinson's disease.Curr Treat Options Neurol. 2006 May;8(3):224-35. doi: 10.1007/s11940-006-0013-y. Curr Treat Options Neurol. 2006. PMID: 16569381
-
Estimation of the postmortem duration of mouse tissue by electron spin resonance spectroscopy.J Toxicol. 2011;2011:973172. doi: 10.1155/2011/973172. Epub 2011 Jun 27. J Toxicol. 2011. PMID: 21776268 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical